Mallcom (India)
- Market cap
- ₹ 567 Cr.
- P/E
- 21.2x
- P/B
- 1.76x
- 52-week range
- 880 – 1,472.8
- ROE
- 10%
- ROCE
- 11%
- Dividend yield
- 0.3%
- Debt / equity
- 0.38
- Sector
- Industrial Products
- Industry
- Other Industrial Products
- Listed on
- NSE, BSE
About
Mallcom (India) Limited is an India-based company, which is engaged in the integrated manufacturer, exporter and distributor of a range of personal protective equipment (PPE). The Company operates through Industrial Safety Products segment. Industrial Safety Products business includes leather hand gloves, industrial work garments, seamless knitted gloves, leather shoe upper, safety shoes, and nitrile dipped gloves. Its Body products include disposable workwear, denim workwear, flame retardant workwear, heavy workwear, HI vis workwear, light workwear, multinorm workwear, occupational workwear, rainwear, soft shell & polo workwear, sustainable workwear, thermal workwear, women's workwear, and feet. The Company serves various industries, including automobile and auto ancillary, agriculture, biotechnology, glass and ceramic, chemical and paint, infrastructure, healthcare, defense and security, logistics and transportation, manufacturing, metal and mining, and pharmaceuticals.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Other Industrial Products: 57 companies →Mallcom (India) against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)21.2 against a typical 22.5: cheaper than most peers (1st = cheapest).25th of 56
- Sales growth−10.6% against a typical +17.6% from a year earlier.30th of 42
- Profit growth−33.3% against a typical −2.6% from a year earlier.31st of 41
- Share price, 3 months−13.1% against a typical −4%.33rd of 49
- Size₹ 567.2 Cr. market value against a typical ₹ 127.7 Cr. (1st = largest).16th of 54
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Adequate safety
Rated A by ICRA- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| India Ratings | — | — | 18 Jun 2026 |
| ICRA | [ICRA]A /[ICRA]A1 | Stable | 22 Jan 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 18 Jun 2026 | Rating action | — | — | India Ratings | ₹ 75.4 Cr. | |
| 22 Jan 2026 | Reaffirmed | [ICRA]A /[ICRA]A1 | — | ICRA | ₹ 120 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 30 Jul 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters |
| 28 May 2026 | Financial Results/Dividend/Other business matters | To consider and approve and take on record the Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial year ended 31st March 2026, to recommend payment of dividend, and any other matter with the permission of the Chairman. |
| 20 Jan 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2025 and other business matters |
| 13 Nov 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2025 and other business matters |
| 4 Aug 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters |
| 19 May 2025 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 108 | 96 | 122 | 102 | 129 | 118 | 138 | 122 | 139 | 131 | 147 | 109 |
| Expenses | 93 | 84 | 106 | 88 | 113 | 102 | 122 | 105 | 129 | 112 | 133 | 96 |
| Operating Profit | 15 | 12 | 16 | 14 | 16 | 15 | 15 | 18 | 10 | 19 | 14 | 14 |
| OPM % | 14.2% | 12.2% | 13.5% | 14% | 12.3% | 13% | 11.2% | 14.4% | 7.1% | 14.7% | 9.3% | 12.5% |
| Other Income | 1 | 1 | 1 | 1 | 2 | 1 | 26 | 0 | 0 | −0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 3 | 3 | −1 | 2 | 2 | 3 | 3 | 2 | 3 | 3 | 4 | 4 |
| Profit before tax | 12 | 9 | 17 | 12 | 15 | 12 | 36 | 13 | 5 | 14 | 8 | 9 |
| Tax % | 26.4% | 22.1% | 30.4% | 25.8% | 30.5% | 26.3% | 17% | 26.7% | 26.1% | 26.6% | 23.7% | 24.9% |
| Net Profit | 9 | 7 | 12 | 9 | 10 | 9 | 30 | 10 | 4 | 10 | 6 | 7 |
| EPS in Rs | 14.66 | 10.95 | 18.93 | 13.67 | 16.19 | 14.47 | 47.71 | 15.79 | 5.99 | 16.27 | 10.1 | 10.53 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 7%
- 5 Years
- 11%
- 3 Years
- 10%
- TTM
- 4%
- 10 Years
- 12%
- 5 Years
- 1%
- 3 Years
- −7%
- TTM
- −29%
- 10 Years
- 18%
- 5 Years
- 11%
- 3 Years
- −3%
- TTM
- —
- 10 Years
- 16%
- 5 Years
- 15%
- 3 Years
- 13%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Mallcom (India) | ₹ 903.00 | ₹ 567 Cr. | 21.2x | 1.8x | 10% | — |
| Lenskart Solutions | ₹ 627.55 | ₹ 1,08,959 Cr. | 181x | 10.7x | 6.7% | 5.7% |
| Poly Medicure | ₹ 1,446.80 | ₹ 14,582 Cr. | 52.1x | 5.5x | 11% | 17.1% |
| Laxmi Dental | ₹ 171.25 | ₹ 946 Cr. | 35.6x | 5x | 12.8% | 9.5% |
| One Global Service Provider | ₹ 372.00 | ₹ 721 Cr. | 17x | 8.3x | 65.2% | 14% |
| Hemant Surgical Industries | ₹ 570.00 | ₹ 829 Cr. | 26x | 3.7x | 18.1% | 7.9% |
Management
- Ajay Kumar Mall
- Executive Chairman of the Board, Managing Director and Chief Executive Officer
- Shyam Sundar Agrawal
- Chief Financial Officer
- Gaurav Raj
- Company Secretary and Compliance Officer
- Giriraj Kumar Mall
- Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.